AGENUS INC AGEN

About AGENUS INC (AGEN): stock profile, AI score and financials

AGENUS INC (AGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AGEN at 41.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,065 of 2,925 stocks — the bottom half of the AI-ranked universe. AGEN scores in the top quartile across balance sheet strength (99.5), profitability (98.8), institutional flow (83.3). Areas of concern include earnings quality (7.3) and free cash flow (7.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 13.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AGENUS INC reports quarterly revenue of $34.5M, net income of $-567.0K, an operating margin of 32.7%. Top institutional holders of AGEN by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. AGEN trades on the Nasdaq exchange and files with the SEC under CIK 1098972. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AGENUS INC directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1098972 →